Korea Institute of Toxicology, located in Daedeok Science Town, the center of the state-of-the art biotechnology in Korea, is a government-funded research institute to evaluate the safety of medicine, bio-related products and chemicals such as agricultural pesticides, food additives and cosmetics.
Established in 1980, KIT has played a leading role in improving advanced technology and building the research framework for the safety assessment in Korea ranging from the test for general toxicology to the test for environmental toxicology. In addition, KIT serves as a core infrastructure in the biotechnology industry.
KIT established Jeonbuk Department of Non-human Primate for inhalation toxicity and non-human primates in Jeongeup, Jeollabuk-do in 2010 and further completed Gyeongnam Department of
Environmental Toxicology and Chemistry in Jinju, Gyeongsangnam-do in March 2012. For the last 30 years, KIT has taken the lead in the research for the safety assessment in Korea and gained an international recognition as a non-clinical laboratory based on state-of-the-art facilities, professional human resources and the high quality of work.
Contact details
141 Gajeong-ro, Yuseong-gu, Daejeon 305-343, Republic of Korea
Tel +82-610-8204 / Fax +82-42-610-8085 / Email: info@kitox.re.kr
The Korean Institute of Toxicology (KIT) is a government-funded research institute that evaluates the safety of medicine, bio-related products and chemicals. PharmaBoardroom talks to Lee Sang-Joon, President of KIT about…
Thibault Janssens, managing director of Bolloré Logistics Korea, shares his expert opinion on the Asian logistics market, and explains how a constant customer-centric focus catering to the specific needs of…
Kukjeon, originally a leading Korean pharmaceutical wholesaler, has in recent years expanded into API manufacturing. Its president, Jay Hong, explains his high-risk strategy to pursue new API business opportunities, and…
YH Shin, CEO of Dr.G, one of Korea’s most successful dermo-cosmetic brands, shares the reasons why he decided to become a dermatologist and later start his own cosmetic company. He…
Historically, Handok has been the entry point of multinational companies to Korea. Now Handok is reinventing itself as a total healthcare company with global ambitions. Its chairman and CEO, Young-jin…
Nic Horridge was recently appointed president of Roche Korea, having spent an extended period in emerging Asian markets. He shares his vision for the Korean affiliate, focused on bringing Roche’s…
iCure is a Korean company applying its advanced transdermal delivery technology to pharmaceuticals and dermo-cosmetics. The company has developed the first-ever transdermal patch for donepezil to reach Phase III clinical…
Myung-Kyu Lee, vice president of the Korea Cosmetic Association, explains how the association helps its member companies both at home and abroad, breaks down the implications of new local and…
Shin Poong is one of the oldest pharmaceutical companies in Korea. Established after the Korean War, the company’s original mission was to provide high-quality and affordable generic medicines to the…
Cure Therapeutics is a startup developing gene and cell therapies in Korea. Its founder David Kim explains where his passion for regenerative therapies stems from, breaks down the main hurdles…
After a long career at leading diagnostics companies in research and business development roles, Young Kuk Yun decided to use his accumulated experience to start a venture dedicated to providing…
Two leading executive recruitment specialists – DHR International’s Helen Park and Egon Zehnder’s Eugene Kim – outline the qualities they look for when hiring pharma country managers for the challenging…
Steve Hong, CEO, and Tony Lim, vice president & COO of Lemon Healthcare, lift the lid on the new streamlined hospital data services they are offering, and the benefits to…
See our Cookie Privacy Policy Here
